6 research outputs found

    Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2) : a randomised, double-blind, placebo-controlled, phase 3 trial

    No full text

    Intravenous versus subcutaneous immunoglobulin \u2013 Authors' reply

    No full text
    Reply to comment for Intravenous subcutaneous immunoglobuli

    Intravenous versus subcutaneous immunoglobulin – Authors' reply

    No full text
    corecore